News
Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary syndrome (CCS) who had prior stenting and were receiving long-term ...
Routine coronary computed tomography (CCT)-based follow-up after percutaneous coronary intervention (PCI) of the left main coronary artery did not reduce death, myocardial infarction (MI), unstable ...
46mon MSN
Early aspirin discontinuation linked to benefits in low-risk patients with myocardial infarction
Among low-risk patients with acute MI who underwent early complete revascularization and received one month of dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy was noninferior to ...
Key take-awaysFor patients with left main coronary artery disease treated with percutaneous coronary intervention (PCI), the optimal surveillance ...
As dues mount to ₹158.7 crore, medical device suppliers halt deliveries to govt. hospitals in Kerala
Medical device suppliers halt deliveries to Kerala government hospitals over ₹158.7 crore unpaid bills, urging prompt intervention for resolution.
Bill Clinton, 79, was recently seen in the Hamptons with someone carrying a device resembling a portable defibrillator, raising concerns about his hea ...
In patients with chronic coronary syndrome on long-term oral anticoagulation, use of aspirin was linked with increased risk for ischemic events, bleeding and death, researchers reported at the ...
Unity Hospital, Highland, Falnir Road, proudly announces the launch of the Philips Azurion Cathlab – Version 3.0, the most advanced interventional suite with exceptional image quality for cardiac, ...
The government has lowered the prices of coronary stents to make cardiac treatment more affordable for patients across the country. The decision of lowering the prices are made to align with those in ...
An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...
Aspirin, long the go-to for heart protection, may be dethroned. New research reveals clopidogrel, a blood thinner, reduces major cardiovascular events ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results